Fatal acute haemopericardium associated with rivaroxaban in a patient with non-valvular atrial fibrillation

被引:0
|
作者
Omer, Siddiq [1 ]
Magezi, Frederick [2 ]
Patel, Martyn [3 ]
Alsawaf, Ali [4 ]
机构
[1] James Paget Univ Hosp, ST4 Geriatr, Great Yarmouth, England
[2] Queen Elizabeth Hosp, ST4 Geriatr, Kings Lynn, England
[3] Norfolk & Norwich Univ Hosp, Norwich, Norfolk, England
[4] Queen Elizabeth Hosp, Kings Lynn, England
关键词
Rivaroxiban; Haemopericardium; Fatal; Older people;
D O I
10.1093/ageing/afz070
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
An 82-year-old female was admitted with chest pain and non-specific T wave changes on her ECG. After 72 hours of conservative management she deteriorated with non-specific symptoms including nausea and a single episode of vomiting. Abdominal and Chest X-rays were unremarkable, blood tests showed worsening Acute Kidney Injury (AKI) on Chronic Kidney Disease (CKD); and raised C-Reactive Protein (CRP) with no obvious symptoms or focus of infection. She rapidly deteriorated going into asystole cardiac arrest and attempts at resuscitation failed. Post-mortem examination suggested the most likely cause of death was acute spontaneous Haemopericardium due to Rivaroxaban therapy which she was on for non-valvular Atrial Fibrillation (AF). We believe that this might be the first reported mortality with Rivaroxaban-associated spontaneous haemopericardium in the UK.
引用
收藏
页码:758 / 760
页数:3
相关论文
共 50 条
  • [11] Non-valvular atrial fibrillation (NVAF)
    Roderick, E
    Cox, J
    [J]. BRITISH JOURNAL OF GENERAL PRACTICE, 1997, 47 (423): : 660 - 661
  • [12] Cardioversion in Non-Valvular Atrial Fibrillation
    Klein, Hermann H.
    Trappe, Hans-Joachim
    [J]. DEUTSCHES ARZTEBLATT INTERNATIONAL, 2015, 112 (50): : 856 - +
  • [13] Non-Traumatic Spontaneous Spinal Subdural Hematoma in a Patient with Non-Valvular Atrial Fibrillation During Treatment with Rivaroxaban
    Castillo, Jessica M.
    Afanador, Hayley F.
    Manjarrez, Efren
    Morales, Ximena A.
    [J]. AMERICAN JOURNAL OF CASE REPORTS, 2015, 16 : 377 - 381
  • [14] HEALTHCARE COSTS ASSOCIATED WITH NON-VALVULAR ATRIAL FIBRILLATION IN ITALY
    Cammarota, S.
    Citarella, A.
    Creazzola, S.
    De Marino, C.
    Izzo, P.
    La Bella, G.
    Piscitelli, R.
    Romagnuolo, F.
    Esposito, E.
    Guida, A.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A386 - A386
  • [15] Patient-reported treatment satisfaction with rivaroxaban in Japanese non-valvular atrial fibrillation patients: an observational study
    Koretsune, Yukihiro
    Kumagai, Koichiro
    Uchiyama, Shinichiro
    Yamashita, Takeshi
    Yasaka, Masahiro
    Watanabe-Fujinuma, Emi
    Banderas, Benjamin F.
    Akiyama, Sayako
    Okayama, Yutaka
    Briere, Jean-Baptiste
    Dickie, Gavin
    Cano, Stefan J.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (12) : 2157 - 2164
  • [16] Comparative Effectiveness of Dabigatran and Rivaroxaban versus Warfarin in Patients With Non-Valvular Atrial Fibrillation
    Bengtson, Lindsay
    Chen, Lin
    MacLehose, Richard
    Lutsey, Pamela
    Alonso, Alvaro
    [J]. CIRCULATION, 2014, 130
  • [17] Clinical and economic consequences of using dabigatran or rivaroxaban in patients with non-valvular atrial fibrillation
    Miguel, Luis Silva
    Ferreira, Jorge
    [J]. REVISTA PORTUGUESA DE CARDIOLOGIA, 2016, 35 (03) : 141 - 148
  • [18] Elevated levels of RDW is associated with non-valvular atrial fibrillation
    Gungor, Baris
    Ozcan, Kazim Serhan
    Erdinler, Izzet
    Ekmekci, Ahmet
    Alper, Ahmet Taha
    Osmonov, Damirbek
    Calik, Nazmi
    Akyuz, Sukru
    Toprak, Ercan
    Yilmaz, Hale
    Yildirim, Aydin
    Bolca, Osman
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2014, 37 (04) : 404 - 410
  • [19] Comparative effectiveness and safety of apixaban, dabigatran, and rivaroxaban in patients with non-valvular atrial fibrillation
    Andersson, Niklas W.
    Svanstrom, Henrik
    Lund, Marie
    Pasternak, Bjorn
    Melbye, Mads
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 268 : 113 - 119
  • [20] Population pharmacokinetic and pharmacodynamic analysis of rivaroxaban in Chinese patients with non-valvular atrial fibrillation
    Xiao-qin Liu
    Yu-fei Zhang
    Hong-yan Ding
    Ming-ming Yan
    Zheng Jiao
    Ming-kang Zhong
    Chun-lai Ma
    [J]. Acta Pharmacologica Sinica, 2022, 43 : 2723 - 2734